The Board of Directors of Singapore Paincare Holdings Limited announced that, following a preliminary review of the unaudited financial statements, the Group is expected to report a significant reduction in profitability for the six months and the twelve months ended 30 June 2023. The significant reduction is mainly due to fair value loss on derivative financial instruments arising from the expiration of options in one of associates, coupled with the increase in employee benefit expense as a result of the increase in headcount from the acquisition and incorporation of new clinics during the year.